Brand Name: Trustiva
Generic Name: Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz
Manufacturer: Hetero
Dosage Form: Tablet
Strength: 200mg, 300mg and 600mg
Composition: Emtricitabine(200mg) + Tenofovir disoproxil fumarate(300mg) + Efavirenz(600mg)
Indication: HIV
Storage: Store at room temperature
Overview
Trustiva (Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz) tablet is used in the treatment of HIV (human immunodeficiency virus). This medication boosts your immune system to fight against infection and prevents the virus from multiplying. Trustiva tablet increases the CD4 cell (white blood cells that protect against infection) count in your blood. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor. If you experience any signs and symptoms while receiving this medicine, inform your doctor immediately.
Pharmacodynamics
Emtricitabine (Trustiva):- a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form Emtricitabine (Trustiva) 5′-triphosphate. Emtricitabine inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5′-triphosphate and by being incorporated into nascent viral DNA which results in chain termination.
Tenofovir Disoproxil Fumarate (Trustiva):- is an acyclic nucleoside phosphonate diester analog of adenosine monophosphate. Tenofovir disoproxil fumarate inhibits the activity of HIV-1 RT by competing with the natural substrate deoxyadenosine 5′-triphosphate and, after incorporation into DNA, by DNA-chain termination.
Efavirenz (Trustiva):- belongs to the NNRTI (non-nucleoside reverse transcriptase inhibitors) class of antiretrovirals. Both nucleoside and non-nucleoside RTIs (reverse transcriptase inhibitors) inhibit the same target, reverse transcriptase enzyme, an essential viral enzyme that transcribes viral RNA into DNA. RTIs bind the enzyme’s active site, NNRTIs act allosterically by binding to a distinct site away from the active site known as the NNRTI pocket. Efavirenz is not effective against HIV-2, as the pocket of the HIV-2 reverse transcriptase has a different structure, which confers intrinsic resistance to the NNRTI class.
Usage
Trustiva tablet is a combination of three anti-HIV medicines: Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz. This medication is not a permanent cure for HIV it only prevents the multiplication of infection in human cells. It is important to take this medicine as prescribed by your doctor. Do not take this medicine in the wrong way as it may lead to some serious side effects. The recommended dose of Trustiva medicine is decided by a doctor according to your previous medical condition and response to the treatment.
Interactions
Trustiva tablets can interact with other medications and it may increase the risk for side effects. Don’t forget to disclose and discuss your previous medical history with the doctor.
Medicine Interactions
Fluconazole
Cisplatin
Tobramycin
Gentamicin
Methotrexate
Lamivudine
Ciprofloxacin
Disease Interactions
Increase in cholesterol levels
Hepatic impairment
CNS orders
Renal dysfunction
Alcohol Interaction
Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Contraindications
Trustiva tablet is not recommended for use in patients with liver disease.
Do not take this medicine if you are allergic to Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz.
Trustiva tablet is not recommended in patients known to be hypersensitive.
This medicine is not recommended for use in patients with severe renal impairment.
Substitutes
Teefavir
Teevir
Viraday
Frostavir
Virotrenz


